Novartis AG-RegNVSEF
13F holders, Q1 2026 (March 31)2holders
0new positions
0sold out
$151.24avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Novartis AG-Reg (NVSEF) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holders were Partners Capital Investment Group, LLP ($4.3M) and Generali Investments CEE, investicni spolecnost, a.s. ($2.6M).
- Company
- Novartis AG-Reg
- CUSIP
- H5820Q150
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 4,106 shares sold, net −4,106 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Partners Capital Investment Group, LLP | 0.16% | Reduce -9.9% | 28,214 | $4.3M |
| Generali Investments CEE, investicni spolecnost, a.s. | 0.14% | Reduce -5.5% | 17,057 | $2.6M |
"% of holder's portfolio" is NVSEF's weight in each manager's 13F, not the share of Novartis AG-Reg the manager owns.